MetLife reported strong fourth-quarter and full-year 2025 results, achieving adjusted earnings of $2.58 per share in Q4 (up 24% year-over-year) and $8.89 per share for the full year (up roughly 10%). The company successfully executed its 'New Frontier' strategy, delivering an adjusted return on equity of 16% (within the 15-17% target) and reducing its direct expense ratio to 11.7%, ahead of schedule. Key performance drivers included record Pension Risk Transfer (PRT) sales of over $14 billion, robust international growth (Asia sales up 18% constant currency), and the acquisition of PineBridge Investments, establishing a new asset management segment with $742 billion in AUM. Capital deployment remained a priority, with $4.4 billion returned to shareholders via buybacks and dividends. Looking ahead to 2026, MetLife forecasts double-digit adjusted EPS growth, continued strong ROE, and share repurchases in line with 2025 levels.
| Metric | Value | Change |
|---|---|---|
| Q4 Adjusted EPS (ex-notable) | $2.58 | +24% YoY |
| FY 2025 Adjusted EPS (ex-notable) | $8.89 | +10% YoY |
| Adjusted Return on Equity (ROE) | 16% | Within 15-17% Target |
| Direct Expense Ratio | 11.7% | -0.6% YoY |
| Q4 Adjusted PFOs | $12.8 Billion | +8% YoY |
| Share Repurchases (FY 2025) | $2.9 Billion | N/A |
| Dividends (FY 2025) | $1.5 Billion | N/A |
| Free Cash Flow (2-yr avg ratio) | 81% | Exceeding 65-75% Target |
| MetLife Investment Mgmt AUM | $742 Billion | +~$142B YoY |
MetLife is aggressively pivoting towards fee-based and capital-light businesses, highlighted by the creation of the MetLife Investment Management (MIM) segment following the PineBridge acquisition. With $742 billion in assets under management (AUM), MIM is expected to drive significant revenue growth (projected 30% in 2026) and achieve a 32% operating margin by 2028. This signals a strategic shift to diversify income streams and leverage the convergence of insurance and asset management.
The Retirement & Income Solutions (RIS) segment is utilizing strategic reinsurance to manage capital efficiency while capturing massive demand for pension de-risking. MetLife originated a record $14 billion in PRT sales and $11 billion in UK longevity transactions in 2025. By leveraging vehicles like Chariot Re and Talcott, the company is growing liabilities and investable assets without straining its balance sheet, supporting MIM's growth.
International markets, particularly Asia and Latin America, are critical growth engines, with constant currency sales growing 18% and 12% respectively in 2025. Management specifically noted the strength in Japan and Korea, and sees a clear pathway for Latin America to reach $1 billion in annual earnings. This geographic diversification mitigates U.S. market specific risks and provides long-term growth runway.
Operational efficiency is being rapidly improved through the integration of AI and emerging technologies. The direct expense ratio dropped to 11.7% in 2025, putting the company 'well ahead of schedule' for its 11.3% target. Management explicitly credited AI tools for reengineering processes and improving speed, indicating that technology is a core pillar of their profitability strategy rather than just a buzzword.
Capital management remains a core tenet of the shareholder value proposition. In 2025, MetLife returned $4.4 billion to shareholders ($2.9B buybacks, $1.5B dividends) while still funding $1.2 billion in acquisitions. The guidance for 2026 buybacks to remain 'in line with 2025' suggests a continued commitment to returning capital, supported by a robust free cash flow generation profile (81% two-year average ratio).
The Group Benefits segment faced headwinds in the disability line during Q4, with results trailing expectations due to higher average severity and higher incidents. While management stated this is within pricing expectations and not a trend, the nonmedical health interest adjusted benefit ratio came in at 72.2%. Investors will need to monitor if this severity pressure persists into 2026, as it could impact the segment's 7-9% earnings growth target.
Variable Investment Income (VII) from real estate and other funds underperformed, coming in below the 2025 target of $1.7 billion. While private equity returned 8.2% (slightly below the 9% bogey), real estate dragged down the total. Management is strategically repositioning the portfolio towards fixed income, but this shift implies a reliance on interest rate environments and could dampen future income volatility if not managed carefully.
Guidance for the Corporate & Other segment implies a significantly larger loss in 2026 ($500M - $700M) compared to the Q4 run rate ($38M loss). Management attributed this to reinsurance transactions (Talcott and Chariot) shifting earnings out of MetLife Holdings. While strategically sound for capital flexibility, this accounting shift creates a drag on consolidated earnings that investors must adjust for in their models.
Macroeconomic volatility in Japan, specifically regarding currency fluctuations and interest rates, led to higher surrenders in Q4 and is expected to cause customers to delay purchasing foreign currency products. While MetLife has a strong platform in Japan, the transition to a new solvency regime (ESR) and the sensitivity to FX moves introduces near-term uncertainty for their largest international market.
Overall: Management exhibited a high level of confidence and discipline throughout the call, emphasizing the successful execution of their strategic priorities one year into the 'New Frontier' plan. The tone was decisive regarding capital allocation and operational efficiency, particularly highlighting the early benefits of AI integration. While acknowledging macroeconomic volatility, particularly in Japan, executives remained focused on controllable factors and expressed strong conviction in their ability to meet medium-term financial commitments.
Confidence: HIGH - Management consistently used definitive language regarding their targets and progress. Phrases like 'well ahead of schedule,' 'laser-focused,' and 'stronger company' underscored their assurance. The specificity of the 2026 guidance across all segments further reinforces high confidence.
Double-digit
15% to 17%
12.1% (includes 50bp impact from PineBridge)
In line with 2025 (~$2.9B)
7% to 9%
$1.6 Billion to $1.8 Billion
Mid-single digits
6% to 8%
$240 Million to $280 Million
Hedging & Uncertainty: Management generally used direct and confident language ('we expect,' 'we are on track'), particularly regarding financial targets and strategic execution. However, hedging appeared when discussing external factors outside their control, such as macroeconomic conditions in Japan ('customers tend to wait for the markets to stabilize') and specific reserve releases in prior years ('positive reserve refinements that benefited adjusted earnings'). They also used temporal hedges regarding the disability experience ('does not make a trend') to prevent overreaction to quarterly noise.
We are entering 2026 as a stronger company with sustained business momentum and expanding market leadership. - Michel Khalaf, President and Chief Executive Officer
We remain laser-focused on the levers we control and on relentless execution to generate responsible growth, deploy capital with rigor, and further drive operating efficiency. - Michel Khalaf, President and Chief Executive Officer
The sheer scale of these numbers highlights the dedication of our people to MetLife's purpose—always with you, building a more confident future. - Michel Khalaf, President and Chief Executive Officer
Overall, an excellent first year, which establishes a strong foundation for our New Frontier strategy. - John McCallion, Chief Financial Officer
We are taking a very grounded view of where that picture is heading. - Ramy Tadros, President, U.S. Business
We really don't have much to say about it... We're very optimistic about our position in Japan. - Lyndon Oliver, President, Asia
This is exactly what we mean when we say we're looking for opportunities that play to our strength. - Ramy Tadros, President, U.S. Business
Analyst Sentiment: Analysts were generally inquisitive and focused on specific operational details, particularly regarding the new MIM segment, the 'New Frontier' execution, and the sustainability of recent underwriting trends. Questions regarding Japan's macro environment and competitive dynamics were prominent, reflecting investor caution about international exposure.
Management Responses: Management responses were detailed and data-driven, effectively addressing concerns about quarterly volatility (e.g., disability severity) by framing them within the context of long-term targets and pricing discipline. Executives demonstrated deep knowledge of regional markets and reinsurance mechanics, providing clear rationale for their strategic moves.
Discussion on Group Benefits renewal season and pricing actions in dental and disability. Management noted robust persistency and improving sales, particularly in disability.
Impact of macroeconomic volatility (FX/Rates) in Japan on sales and surrenders. Management acknowledged temporary delays in purchasing but maintained optimism due to product breadth.
Inquiries about the new MIM segment, specifically regarding the Brighthouse relationship and the integration of PineBridge. Management emphasized diversification and minimal EPS impact from worst-case scenarios.
Questions regarding the impact of AI on employment levels and Group Benefits. Management stated they are incorporating observed employment actions into their outlook but remain comfortable due to diversification.
Detailed breakdown of the Corporate & Other loss guidance, specifically the impact of reinsurance transactions (Talcott/Chariot) on earnings run rates.
MetLife is demonstrating strong execution under its 'New Frontier' strategy, successfully balancing growth with capital discipline. The company is hitting or exceeding key financial targets (ROE, EPS, Expense Ratio) while transforming its business mix towards higher-growth, fee-based areas like Asset Management (MIM) and International. The 24% jump in Q4 EPS and the robust 2026 guidance for double-digit growth signal momentum. While minor headwinds exist in disability underwriting and Japan macro volatility, the strategic use of reinsurance and the diversification of revenue streams mitigate these risks. The commitment to returning capital ($4.4B in 2025) combined with a clear path to $25B in free cash flow over five years makes the equity attractive for value and income investors.
Management expects long-term rates to be modestly higher and the yield curve to steepen in 2026. This is viewed as a positive development for net interest margins and investment income.
MetLife expects the US dollar to be stable in 2026 relative to 2025. However, recent volatility in the Yen caused temporary fluctuations in sales and surrenders in Japan.
Management is observing employment actions by clients, including those driven by AI, and has incorporated these trends into their 2026 outlook for Group Benefits. They rely on diversification to offset sector-specific ebbs and flows.
The company is using a 5% annual return assumption for the S&P 500 in its guidance. Favorable equity markets contributed to net derivative losses in GAAP results but support Variable Investment Income.